Insight Molecular Diagnostics (IMDX) Capital Expenditures Growth (3y) (2018 - 2025)
Insight Molecular Diagnostics (IMDX) Capital Expenditures Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.89% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 6.92% |
| Jun 30, 2025 | -32.16% |
| Mar 31, 2025 | -41.85% |
| Dec 31, 2024 | -18.89% |
| Sep 30, 2024 | -39.56% |
| Jun 30, 2024 | -32.10% |
| Mar 31, 2024 | -69.45% |
| Dec 31, 2023 | 16.73% |
| Sep 30, 2023 | -45.37% |
| Dec 31, 2022 | -3.77% |
| Jun 30, 2022 | 366.68% |
| Mar 31, 2022 | 506.41% |
| Sep 30, 2021 | 252.44% |
| Jun 30, 2021 | 229.83% |
| Mar 31, 2021 | 452.22% |
| Dec 31, 2020 | 202.45% |
| Sep 30, 2020 | 159.79% |
| Jun 30, 2020 | 132.63% |
| Mar 31, 2020 | 40.10% |